Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.22 HKD | +0.38% | +0.97% | -21.39% |
02/05 | Alphamab Oncology's 2023 Loss Narrows as Revenue Rises | MT |
10/04 | Alphamab Oncology Presents Phase-I Clinical Trial Results at 2024 AACR Annual Meeting | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.39% | 625M | |
+27.41% | 48.16B | |
-1.12% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.19% | 25.59B | |
-22.74% | 18.96B | |
+8.10% | 12.92B | |
+29.02% | 12.03B | |
-2.29% | 11.77B |
- Stock Market
- Equities
- 9966 Stock
- News Alphamab Oncology
- Alphamab Oncology : Nomura Starts Alphamab Oncology at Buy With HK$17.2 Price Target